Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Medicine

Internal Medicine

Pediatrics

Emergency Medicine

Neurology

Show all topics

DOI

10.1016/s0140-6736(21)01744-x

License

CC-BY

Other Formats

PDF